AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.

Join our Talent Network Be the first to receive job updates and news from AstraZeneca Sign up

AstraZeneca was founded in 1999 through the merger of Sweden's Astra AB and the UK's Zeneca Group PLC. This strategic merger combined each company’s strengths to drive scientific …

Find press releases and media updates covering our latest science news, alongside AstraZeneca's financial, corporate, partnering and sustainability updates.

If you are in the United States and would like additional information regarding AstraZeneca products, or you are a third party with an offer of services for AstraZeneca, you can contact the AstraZeneca …

Oncology BioPharmaceuticals Cardiovascular, Renal and Metabolism Respiratory & Immunology Vaccines and Immune Therapies Rare Disease All medicines

AstraZeneca’s deep pipeline of medicines focusing on their key therapeutic areas.

Our performance AstraZeneca sustained strong momentum in 2024, with Total Revenue up 18% (21% at CER) and Reported EPS up 18% (29% at CER). Core EPS was up 13% (19% at CER).

Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific …

As a global, science-led biopharmaceutical company, AstraZeneca is focused on the discovery, development, and commercialization of medicines for millions of patients worldwide.